Home Home Home Inbox Home Search

Event

Preclinical Investigation of Safety, Pharmacokinetics and Neoantigenicity of a Liquid Formulation of the Alpha-1 Proteinase Inhibitor Prolastin-C® [Board No. P1392]

Location: Board no. P1392
Session Type: Thematic Poster Session
Sunday
May
20
11:15 AM
1:00 PM
Home Home Home Inbox Home Search